Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/375"

PredicateValue (sorted: default)
rdfs:label
rdf:type
?:Evidence_enzyme_system
?:Evidence_type
?:content
"The FDA recommends warfarin as a preferred CYP2D6 substrate for in vivo studies in it most recent guidance document (See Table 2, p. 19) and expressly mentions that S-warfarin should be target of chemical analysis on 9, 1st paragraph."
dc:creator
dc:date
"09/24/2009 15:39:40"
rdfs:seeAlso

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ S-warfarin_primary_total_clearance_enzyme_cyp2c9, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1656 }

Context graph